What Matters to Spanish Patients and Physicians when Facing Decisions for Gep-Net? An Exploration Using a Reflective Multicriteria Shared-Decisionmaking Framework

Patients with slow-growing, unresectable, well/moderately-differentiated asymptomatic gastroenteropancreatic-neuroendocrine tumors (GEP-NETs) may have to decide between initiating treatment with somatostatin analogs (SSAs) or pursuing watchful-waiting. We explored drivers of decision among Spanish patients and physicians using a shared-decisionmaking multicriteria framework. The framework, designed based on EVIDEM structure, literature review...